EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN

The article is dedicated to the use of immunomodulators in children, conditions, at which the prescription of this group of drugs is reasonable, action mechanism and also efficacy are given. In particular, the authors give their observation results for a group of HPV-infected children vaccinated by...

Full description

Saved in:
Bibliographic Details
Published inPediatricheskai͡a︡ farmakologii͡a︡ : nauchno-prakticheskiĭ zhurnal Soi͡u︡za pediatrov Rossii Vol. 10; no. 1; pp. 70 - 73
Main Authors Ruleva, A. A., Kharit, S. M., Nacharova, E. P., Fridman, I. V.
Format Journal Article
LanguageEnglish
Russian
Published Union of pediatricians of Russia 13.02.2013
Subjects
biologic response modifier therapy
children
hiv
live vaccines
Online AccessGet full text

Cover

More Information
Summary:The article is dedicated to the use of immunomodulators in children, conditions, at which the prescription of this group of drugs is reasonable, action mechanism and also efficacy are given. In particular, the authors give their observation results for a group of HPV-infected children vaccinated by live vaccines (rubella and divalent measles-parotitis vaccine) together with pidotimod usage. No undesirable phenomena were registered in the postvaccinal period. Dynamics of immunological indicators did not change significantly. Seroconversion level of measles antibodies totaled 100% by the 30th observation day.
ISSN:1727-5776
2500-3089
DOI:10.15690/pf.v10i1.591